Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2000

01-09-2000 | Originales

Homogeneización de la dosis en radioterapia, en las técnicas de campos opuestos, por medio de campos estáticos adicionales (segmentos)

Authors: J. Pérez Calatayud, I. Petschen Verdaguer, F. Lliso Valverde, A. Tormo Micó, V. Carmona Meseguer, M. Tortajada Azcutia, A. González López, A. González Sanchís, P. Almendros Blanco, J. C. Ruiz Rodríguez

Published in: Clinical and Translational Oncology | Issue 5/2000

Login to get access
Metadata
Title
Homogeneización de la dosis en radioterapia, en las técnicas de campos opuestos, por medio de campos estáticos adicionales (segmentos)
Authors
J. Pérez Calatayud
I. Petschen Verdaguer
F. Lliso Valverde
A. Tormo Micó
V. Carmona Meseguer
M. Tortajada Azcutia
A. González López
A. González Sanchís
P. Almendros Blanco
J. C. Ruiz Rodríguez
Publication date
01-09-2000
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2000
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02979566

Other articles of this Issue 5/2000

Clinical and Translational Oncology 5/2000 Go to the issue

Announcement

Información

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine